Studies that explore the role of innate immunity and NcP
Study and reference | Mechanism involved | NcP condition |
---|---|---|
Mast cells involvement | ||
Blanco et al. [32] | Increased mast cells correlate with pain, fatigue | FM patients |
Salemi et al. [33] | Increased mast cells and mediators such as IL 1, IL 6, TNF-alpha, IL 17 | FM patients |
Murphy et al. [34] | Increased mast cells and mediators such as IL 1, IL 6, TNF-alpha, IL 17 | Chronic pelvic pain patients |
Tsilioni et al. [36] | Increase in serum substance P which increases mast cell activation | FM patients |
Liu et al. [41] | Higher levels of mucosal leptin, linked to increased levels of mast cells through the induction of IFN and the suppression of IL 4 | IBS patients |
Li et al. [43] | Mast cell accumulation, activation, and degranulation in proximity to peptidergic nerve fibers were mediated by substance P | CRPS patients |
Neutrophils involvement | ||
Caxaria et al. [46] | Neutrophils invade sensory ganglia, increasing mechanical hyperalgesia and favouring sensitization of spinal cord neurons | FM patients |
Microglia and astrocyte activation | ||
Atta et al. [21] | M1/M2 polarization with an augmented pro-inflammatory signature (mediated by the M1 phenotype, which secretes TNF-alpha, IL 1β, and IL 6) | FM patients |
Ye et al. [54] | Glial activation with an increase of pro-inflammatory cytokines and overexpression of purinergic receptors | Orofacial pain patients |
Linan-Rico et al. [55] | Enteric glia activation, linked to toll-like receptor 4 signaling | IBS patient |
Dodds et al. [56] | Glial activation by toll-like receptors, purinergic receptors, and chemokines | Female patients with pelvic pain |
Lao et al. [57] | Microglia activation is mediated by purinergic receptors, TNF-alpha, and IL 1β | Male patient with pelvic pain |
Tian et al. [58] | Astrocytes activation via metalloproteinase pathway | CRPS patients |
NK recruitment | ||
Verma et al. [60] | NK cells recruitment and pro-inflammatory cytokines spill over | FM patients |
NcP: nociplastic pain; FM: fibromyalgia; IL: interleukin; TNF: tumor necrosis factor; IBS: irritable bowel syndrome; IFN: interferon; CRPS: complex regional pain syndrome; NK: natural killers. MI/M2 microglia phenotypes (see text for details)
MG and AC: Conceptualization, Investigation, Writing—original draft, Writing—review & editing. AP: Investigation, Writing—original draft, Writing—review & editing. FP: Conceptualization, Validation, Writing—review & editing, Supervision. GV: Validation, Writing—review & editing, Supervision. All authors read and approved the submitted version.
Giustino Varrassi, the Editorial Board Member and a Guest Editor of Exploration of Immunology, had no involvement in the decision-making or the review process of this manuscript. The other authors declare no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2025.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.